Supporting economically disadvantaged tobacco users to help them stop: time to review priorities?
Nicotine vaccination—does it have a future?
The ‘drug policy ratchet’: why do sanctions for new psychoactive drugs typically only go up?
VICE RATCHETS
NEW EVIDENCE ON THE TENUOUS STATE OF EVIDENCE-BASED DRUG POLICY
WIDENING THE DEBATE ON THE DRUG POLICY RATCHET: RESPONSE TO COMMENTARIES
Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment
LEGISLATIVE STRATEGIES OTHER THAN LEGALIZING ILLICIT OPIOIDS MAY HELP TO REDUCE OVERDOSE FATALITIES
Addiction Research Centres and the Nurturing of Creativity
Efficacy of the nicotine vaccine 3′-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial
Treatment with a nicotine vaccine does not lead to changes in brain activity during smoking cue exposure or a working memory task
Vaccination against smoking: an annotated agenda for debate. A review of scientific journals, 2001–13
Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence
Commentary on Garbutt et al . (2014): Can we predict who benefits from naltrexone in the treatment of alcohol dependence?
Sustaining motivational interviewing: a meta-analysis of training studies
Commentary on Schwalbe et al . (2014): Two wishes for the future of motivational interviewing—workshops with fewer learning targets and sustainable coaching
The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study
The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study
Commentary on Degenhardt et al . (2014): Access to opioid substitution therapy in prison is not enough—the crucial role of post-release retention in preventing drug-related harms
The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study
Commentary on Degenhardt et al . (2014): Regional variation in the global burden of disease attributable to opioid dependence—where do the data come from and does population size matter?
RESPONSE TO HSER ET AL . (2014): THE NECESSITY FOR MORE AND BETTER DATA ON THE GLOBAL EPIDEMIOLOGY OF OPIOID DEPENDENCE
Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis
Commentary on Ort et al . (2014): What next to deliver on the promise of large scale sewage-based drug epidemiology?
Using cognitive modelling to investigate the psychological processes of the Go/NoGo discrimination task in male abstinent heroin misusers
Effects of depressive symptoms on antecedents of lapses during a smoking cessation attempt: an ecological momentary assessment study
Youth tobacco use type and associations with substance use disorders
INACCURACIES IN EDITORIAL BY BABOR & MILLER
RESPONSE TO BABOR & MILLER EDITORIAL ‘MCCARTHYISM, CONFLICT OF INTEREST AND ADDICTION 'S NEW TRANSPARENCY DECLARATION PROCEDURES’
RESPONSE TO BABOR & MILLER EDITORIAL ‘MCCARTHYISM, CONFLICT OF INTEREST AND ADDICTION 'S NEW TRANSPARENCY DECLARATION PROCEDURES’
YOUTH ALCOHOL POLARIZATION EFFECTS IN REGIONAL BUT NOT NATIONAL DATA
NO POLARIZATION IN YOUTH DRINKING IN STOCKHOLM COUNTY: RESPONSE TO HALLGREN
DEMONS: OUR CHANGING ATTITUDES TO ALCOHOL, TOBACCO AND DRUGS
HOW TO REGULATE CANNABIS: A PRACTICAL GUIDE
Corrigendum
New Books
News and Notes